LINE vs. PFE
LINE (Lineage, Inc.) and PFE (Pfizer Inc.) are both stocks. LINE operates in REIT - Industrial (Real Estate), while PFE operates in Drug Manufacturers - General (Healthcare). Over the past year, LINE returned 7.78% vs 14.27% for PFE. At a 0.31 correlation, their price movements are largely independent.
Performance
LINE vs. PFE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LINE achieves a 29.07% return, which is significantly higher than PFE's 8.79% return.
LINE
- 1D
- -0.34%
- 1M
- 15.53%
- YTD
- 29.07%
- 6M
- 24.54%
- 1Y
- 7.78%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PFE
- 1D
- 0.15%
- 1M
- 3.47%
- YTD
- 8.79%
- 6M
- 4.79%
- 1Y
- 14.27%
- 3Y*
- -7.78%
- 5Y*
- -3.35%
- 10Y*
- 2.11%
LINE vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
LINE Lineage, Inc. | 29.07% | -37.20% | -27.57% |
PFE Pfizer Inc. | 8.79% | 0.65% | -8.86% |
Correlation
The correlation between LINE and PFE is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Jul 25, 2024 | 0.31 |
Fundamentals
LINE:
$10.08B
PFE:
$150.21B
LINE:
-$0.64
PFE:
$1.31
LINE:
1.89
PFE:
2.36
LINE:
1.25
PFE:
1.67
LINE:
$5.36B
PFE:
$63.32B
LINE:
$410.00M
PFE:
$43.91B
LINE:
$1.12B
PFE:
$16.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LINE vs. PFE — Risk / Return Rank
LINE
PFE
LINE vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Lineage, Inc. (LINE) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LINE | PFE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.45 | ||
| Sortino ratioReturn per unit of downside risk | -0.57 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.12 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | 0.12 | 1.13 | -1.00 |
| Martin ratioReturn relative to average drawdown | 0.23 | 2.27 | -2.04 |
Loading charts...
Drawdowns
LINE vs. PFE - Drawdown Comparison
The maximum LINE drawdown since its inception was -61.74%, smaller than the maximum PFE drawdown of -69.24%. Use the drawdown chart below to compare losses from any high point for LINE and PFE.
Loading charts...
Drawdown Indicators
| LINE | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.74% | -69.24% | +7.50% |
Max Drawdown (1Y)Largest decline over 1 year | -28.46% | -11.47% | -16.99% |
Max Drawdown (3Y)Largest decline over 3 years | — | -40.43% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -58.96% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -58.96% | — |
Current DrawdownCurrent decline from peak | -45.65% | -45.68% | +0.03% |
Average DrawdownAverage peak-to-trough decline | -40.99% | -22.90% | -18.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.15% | 5.70% | +9.45% |
Volatility
LINE vs. PFE - Volatility Comparison
Lineage, Inc. (LINE) has a higher volatility of 10.80% compared to Pfizer Inc. (PFE) at 5.07%. This indicates that LINE's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LINE | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.80% | 5.07% | +5.73% |
Volatility (6M)Calculated over the trailing 6-month period | 28.50% | 14.62% | +13.88% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.90% | 23.84% | +14.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.74% | 25.48% | +11.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.74% | 23.89% | +12.85% |
Dividends
LINE vs. PFE - Dividend Comparison
LINE's dividend yield for the trailing twelve months is around 4.76%, less than PFE's 6.56% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LINE Lineage, Inc. | 4.76% | 6.03% | 1.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 6.56% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Financials
LINE vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Lineage, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LINE vs. PFE - Profitability Comparison
LINE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lineage, Inc. reported a gross profit of 0.00 and revenue of 1.30B. Therefore, the gross margin over that period was 0.0%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.
LINE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lineage, Inc. reported an operating income of 36.00M and revenue of 1.30B, resulting in an operating margin of 2.8%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.
LINE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lineage, Inc. reported a net income of -46.00M and revenue of 1.30B, resulting in a net margin of -3.6%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.
Frequently Asked Questions
LINE and PFE have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LINE has higher volatility (10.80%) compared to PFE (5.07%). In terms of maximum drawdown, LINE dropped -61.74% vs PFE's -69.24%.
PFE currently has the higher Sharpe Ratio (0.54 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LINE and PFE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer